Provided by Tiger Trade Technology Pte. Ltd.

Omnicell

32.25
-1.3900-4.13%
Volume:534.30K
Turnover:17.31M
Market Cap:1.47B
PE:38.33
High:33.37
Open:33.26
Low:32.12
Close:33.64
52wk High:55.00
52wk Low:29.06
Shares:45.44M
Float Shares:43.94M
Volume Ratio:0.83
T/O Rate:1.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.8415
EPS(LYR):0.0400
ROE:3.06%
ROA:1.52%
PB:1.13
PE(LYR):806.25

Loading ...

Omnicell Inc : Piper Sandler Raises Target Price to $57 From $49

THOMSON REUTERS
·
Apr 28

Omnicell Shares Rally Premarket After Swing to 1Q Profit

Dow Jones
·
Apr 28

Omnicell Shares Gain 18% Premarket After Co Raises 2026 Adj. Profit Forecast

THOMSON REUTERS
·
Apr 28

Stock Track | Omnicell Soars 10.95% in Pre-Market on Strong Q1 Earnings Beat and Raised Full-Year Guidance

Stock Track
·
Apr 28

Omnicell publishes investor presentation on autonomous pharmacy, OmniSphere platform and Titan XT system

Reuters
·
Apr 28

Omnicell Q1 adjusted EPS beats helped by connected devices demand, raises FY outlook

Reuters
·
Apr 28

GUIDANCE: (OMCL) Omnicell Expects 2026 Revenue Range $1.22B - $1.26B, vs. FactSet Est of $1.24B

MT Newswires Live
·
Apr 28

Omnicell Q1 FY26 revenue rises 15% to $310 million; net income totals $11 million

Reuters
·
Apr 28

Omnicell Q1 Adj. EPS $0.55 Beats $0.32 Estimate, Sales $309.880M Beat $303.992M Estimate

Benzinga Earnings
·
Apr 28

BRIEF-Omnicell Q1 Revenue USD 310 Million

Reuters
·
Apr 28

Omnicell Announces First Quarter 2026 Financial Results

THOMSON REUTERS
·
Apr 28

Omnicell Outlook Q2 Adjusted EPS USD 0.4-0.48

THOMSON REUTERS
·
Apr 28

Omnicell Q1 Adjusted Ebitda USD 45 Million

THOMSON REUTERS
·
Apr 28

Omnicell Q1 Adjusted EPS USD 0.55 VS. Ibes Estimate USD 0.33

THOMSON REUTERS
·
Apr 28

Omnicell Outlook Q2 Total Revenue $307 Million - $313 Million

THOMSON REUTERS
·
Apr 28

Omnicell Inc - Sees 2026 Total Revenues $1.215 Bln-$1.255 Bln

THOMSON REUTERS
·
Apr 28

Omnicell Inc - Sees 2026 Adj EPS $1.80-$2.00

THOMSON REUTERS
·
Apr 28

Omnicell Is Maintained at Overweight by Wells Fargo

Dow Jones
·
Apr 23

Analysts Conflicted on These Healthcare Names: Passage Bio (PASG) and Omnicell (OMCL)

TIPRANKS
·
Apr 21

Press Release: Omnicell to Release First Quarter 2026 Financial Results on April 28, 2026

Dow Jones
·
Apr 14